Review Article

An Overview of Meta-Analyses of Danhong Injection for Unstable Angina

Table 1

Characteristics of included trials.

Author
Year
Electronic databasesAssessment tool of primary studiesStudy typeStudy timeNumber of trails
(participants)
Experiment group
(participants)
Control group
(participants)
Course
(d)
Main outcomeAdverse eventsAuthors’ conclusion

Wangand Hu, 2010 [19]VIP, CNKI, and WanfangJadadRCT2000–200913
(1183)
CMT plus DHI
(623)
CMT
(560)
7–15Effectiveness for RAS and ECGYesEffectiveness of RAS and ECG Incidence of heart event

Xu et al.,
2010 [20]
Cochrane Library, Medline, Embase, CBM disc, and CNKIJadadRCT1991–20109
(771)
CMT plus DHI
(401)
CMT
(370)
10–15Effectiveness for RAS and ECGNoEffectiveness and safety for UA

Xu et al.,
2011 [21]
Cochrane Library, Medline, Embase, CBM disc, and CNKIJadadRCT1991–200919
(1940)
CMT plus DHI
(991)
CMT
(949)
10–21Effectiveness for RAS and ECGYesEffectiveness for UA

Yang et al.,
2011 [22]
CNKI, Wanfang, VIP, and CBM discNMRCT2000–201012
(1337)
CMT plus DHI
(NM)
CMT
(NM)
NMEffectiveness for ECG and RASNMEffectiveness and safety for UA

Cui et al.,
2012 [23]
Pubmed, Medline, CNKI, Wanfang, and Cochrane LibraryJadadRCTUp to 201023
(2675)
CMT plus DHI
(1382)
CMT
(1293)
10–28Effectiveness for ECG and RAS
Regulation of HDL-C, LDL-C, and
HS-CRP
NM Or noEffectiveness for ECG Regulation of HDL-C, LDL-C, and HS-CRP

DHI: Danhong injection; NM: not mentioned; CMT: conventional medicine treatment, including the combination of platelet aggregation inhibitor (aspirin), nitrates, beta-blockers, calcium channel blockers, and ACE inhibitors; RAS: resolution of angina symptoms; ECG: electrocardiogram; HDL-C: high density lipoprotein-cholesterol; LDL-C: low density lipoprotein-cholesterol; HS-CRP: high sensitive C-reactive protein; indicates the intervention of 2 trials that were conventional medicine treatment plus DHI versus conventional medicine treatment plus Danshen injection; CNKI: China National Knowledge Infrastructure; CBM disc: Chinese Biology Medicine disc.